rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Rock Soffer

Director

Company insider

Files Form 4 as: Director, Longeveron.

In numbers

Trades disclosed
25
Buys
6
Sells
6
Bought
$399K
Sold
$182K
Companies
1
Companies where not an officer
1
First trade
12 Feb 2021
Last trade
19 Aug 2026
Last filed
21 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LGVN LongeveronDirector · Biotechnology · last 19 Aug 20266 buys · 6 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
19 Aug 2026filed 21 Aug 2026LGVN LongeveronBiotechnologySEC FORM 4 Code A—36,000 at $0.00filing
19 Aug 2026filed 21 Aug 2026LGVN LongeveronBiotechnologySEC FORM 4 Code A—36,000 at $0.00filing
15 Jul 2025filed 17 Jul 2025LGVN LongeveronBiotechnologySEC FORM 4 Code A—17,000 at $0.00filing
30 May 2025filed 2 Jun 2025LGVN LongeveronBiotechnologySEC FORM 4 Sold$14K11,000 at $1.25filing
29 May 2025filed 2 Jun 2025LGVN LongeveronBiotechnologySEC FORM 4 Sold$13K10,000 at $1.30filing
22 May 2025filed 27 May 2025LGVN LongeveronBiotechnologySEC FORM 4 Sold$2,6402,000 at $1.32filing
15 Aug 2024filed 19 Aug 2024LGVN LongeveronBiotechnologySEC FORM 4 Code A—23,500 at $0.00filing
11 Apr 2024filed 12 Apr 2024LGVN Longeveronoption or derivative · BiotechnologySEC FORM 4 Code P$4,14931,915 at $0.13filing
11 Apr 2024filed 12 Apr 2024LGVN LongeveronBiotechnologySEC FORM 4 Bought$75K31,915 at $2.35filing
10 Apr 2024filed 12 Apr 2024LGVN Longeveronoption or derivative · BiotechnologySEC FORM 4 Code P$14K106,383 at $0.13filing
10 Apr 2024filed 12 Apr 2024LGVN LongeveronBiotechnologySEC FORM 4 Bought$250K106,383 at $2.35filing
21 Dec 2023filed 26 Dec 2023LGVN Longeveronoption or derivative · BiotechnologySEC FORM 4 Code A—12,000 at $0.00filing
8 Sep 2023filed 12 Sep 2023LGVN Longeveronoption or derivative · BiotechnologySEC FORM 4 Code M—30,000 at $0.00filing
8 Sep 2023filed 12 Sep 2023LGVN LongeveronBiotechnologySEC FORM 4 Code M$90K30,000 at $3.00filing
21 Dec 2022filed 22 Dec 2022LGVN Longeveronoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
24 May 2022filed 24 May 2022LGVN LongeveronBiotechnologySEC FORM 4 Sold$30K4,000 at $7.50filing
23 May 2022filed 24 May 2022LGVN LongeveronBiotechnologySEC FORM 4 Sold$62K8,000 at $7.78filing
20 May 2022filed 24 May 2022LGVN LongeveronBiotechnologySEC FORM 4 Sold$60K7,500 at $8.06filing
17 May 2022filed 19 May 2022LGVN LongeveronBiotechnologySEC FORM 4 Code J—500,182 at $0.00filing
13 Apr 2022filed 15 Apr 2022LGVN LongeveronBiotechnologySEC FORM 4 Code J—139,912 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care12

Buys in green, sells in red, by the company’s sector.

Related people

Stephen H. WillardChief Executive Officer · Chief Executive Officer at Longeveron, filing Form 4 there in the last year
Paul T. LehrGeneral Counsel, Secretary · General Counsel, Secretary at Longeveron, filing Form 4 there in the last year
Nataliya AgafonovaChief Medical Officer · Chief Medical Officer at Longeveron, filing Form 4 there in the last year
Nirav S. JhaveriChief Financial Officer · Chief Financial Officer at Longeveron, filing Form 4 there in the last year
Devin BlassCTO & SVP of CMC · CTO & SVP of CMC at Longeveron, filing Form 4 there in the last year